AAP Recommends Routine HIV Screening for all Adolescents Starting at Age 15
January 05, 2022

The AAP updated its guidance to recommend routine HIV screening at least once in all adolescents aged ≥15 years and at-risk youth be rescreened annually.

New Analysis Projects Older Ages and Rising Number of Patients with HIV by 2030
December 02, 2021

Nearly 25% of patients with HIV who use antiretroviral therapy will reach 65 years of age or older by 2030, researchers projected in a new analysis.

Black Women with HIV at Highest Risk for Premature Mortality a 21-year Study Finds
October 01, 2021

IDWeek 2021: Despite declining mortality rates among patients with HIV in the past 2 decades, a new study finds significant disparities in gender and race.

People Living with HIV Use Fewer Essential Clinical Services and Less Frequently During Pandemic
October 01, 2021

Viral-load monitoring rates decreased and clinic visits declined overall despite an increase in use of telehealth.

HIV Infection Linked to Elevated Risk for Sudden Cardiac Death in Veterans, New Study Shows
September 09, 2021

Patients with HIV had a 14% higher risk of sudden cardiac death than those without HIV, according to a large analysis of US veterans.

Vaccine Hesitancy in Georgia HIV Clinic Reflects Well-worn Myths, Resistance to Facts
July 22, 2021

Rodger MacArthur, MD, was in his HIV clinic last week and queried his COVID-19 vaccine-hesitant/resistant patients about their reasons. The refrain was familiar and discouraging.

Novavax, J&J Vaccine Candidates Effective Against COVID-19, Variants
January 29, 2021

Vaccines from both companies were significantly effective against COVID-19 and show promise against variants from the UK and South Africa.

FDA Approval Granted for First Long-acting Injectable HIV Therapy
January 25, 2021

Cabotegravir and rilpivirine, injectable formulation is administered once-weekly, reducing treatment days for adults with HIV from 365 to 12.

FDA Announced Approval of Second HIV-Prevention Drug
October 04, 2019

The FDA announced October 3 approval of Descovy®, making it the second drug to receive indication for HIV pre-exposure prophylaxis.

10 New Drugs for Primary Care: Q1 2019
April 11, 2019

Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus, and 8 more new and approved drugs.